Return On Equity of Aligos Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aligos Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Aligos Therapeutics, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -28%, a 92% increase year-over-year.
  • Aligos Therapeutics, Inc. annual Return On Equity for 2025 was -28%, a 92% increase from 2024.
  • Aligos Therapeutics, Inc. annual Return On Equity for 2024 was -354%, a 204% decline from 2023.
  • Aligos Therapeutics, Inc. annual Return On Equity for 2023 was -116%, a 56% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Aligos Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -28% +326% +92% 01 Oct 2025 31 Dec 2025
Q3 2025 -132% -18% -16% 01 Jul 2025 30 Sep 2025
Q2 2025 -124% -13% -12% 01 Apr 2025 30 Jun 2025
Q1 2025 -104% +40% +28% 01 Jan 2025 31 Mar 2025
Q4 2024 -354% -238% -204% 01 Oct 2024 31 Dec 2024
Q3 2024 -114% -10% -9.6% 01 Jul 2024 30 Sep 2024
Q2 2024 -111% -24% -28% 01 Apr 2024 30 Jun 2024
Q1 2024 -144% -70% -93% 01 Jan 2024 31 Mar 2024
Q4 2023 -116% -42% -56% 01 Oct 2023 31 Dec 2023
Q3 2023 -104% -29% -39% 01 Jul 2023 30 Sep 2023
Q2 2023 -87% -13% -18% 01 Apr 2023 30 Jun 2023
Q1 2023 -75% +0.83% +1.1% 01 Jan 2023 31 Mar 2023
Q4 2022 -74% -7.5% -11% 01 Oct 2022 31 Dec 2022
Q3 2022 -75% -13% -20% 01 Jul 2022 30 Sep 2022
Q2 2022 -73% +39% +35% 01 Apr 2022 30 Jun 2022
Q1 2022 -75% +192% +72% 01 Jan 2022 31 Mar 2022
Q4 2021 -67% -480% -116% 01 Oct 2021 31 Dec 2021
Q3 2021 -62% 01 Jul 2021 30 Sep 2021
Q2 2021 -112% 01 Apr 2021 30 Jun 2021
Q1 2021 -267% 01 Jan 2021 31 Mar 2021
Q4 2020 413% 01 Oct 2020 31 Dec 2020

Aligos Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -28% +326% +92% 01 Jan 2025 31 Dec 2025
2024 -354% -238% -204% 01 Jan 2024 31 Dec 2024
2023 -116% -42% -56% 01 Jan 2023 31 Dec 2023
2022 -74% -7.5% -11% 01 Jan 2022 31 Dec 2022
2021 -67% -480% -116% 01 Jan 2021 31 Dec 2021
2020 413% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.